Lauren Pruett

Ms. Lauren Pruett


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2021 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
LPLauren Pruett
Lauren Pruett
CJChristian H. Jenkins
Christian H. Jenkins
NSNeharika S. Singh
Neharika S. Singh
KCKatarina J. Catallo
Katarina J. Catallo
DGDonald R. Griffin
Donald R. Griffin

17 May 2021 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
LPLauren Pruett
Lauren Pruett
RERegan Ellis
Regan Ellis
MMMeghan McDermott
Meghan McDermott
CRColleen Roosa
Colleen Roosa
DGDonald Griffin
Donald Griffin
Microporous annealed particle (MAP) hydrogel has been a promising scaffold platform technology to promote immediate tissue integration in injured tissue environments. The addition of growth factors has the potential to accelerate tissue integration and enhance scaffold-mediated healing. Growth factor releasing scaffolds face the translational hurdle of limited solubilized protein shelf stability; however, to address this hurdle we present a lyophilized MAP scaffold which can be effectively rehydrated directly prior to use. Our new approach includes a heterogenous MAP scaffold wherein 5% of the microgels contain immobilized heparin loaded with epidermal growth factor (EGF) at 1 μg mL−1. We demonstrate that these scaffolds, which are directly loaded with EGF following lyophilization maintain equivalent properties to scaffolds loaded passively via diffusion into water-swollen microgels, including EGF release profiles and cell migration studies that did not significantly differ. Further, these heterogeneous scaffolds exhibit a significant increase in cellular migration in vitro and quicker re-epithelialization in vivo. This progress on spatially heterogenous growth factor release from MAP scaffolds has great potential to improve complex wound treatment and advance the field of growth factor releasing scaffolds.

23 February 2023 in npj Regenerative Medicine
Verified
Journal Article
Open access
PDF file
LPLauren Pruett
Lauren Pruett
HKHannah L. Kenny
Hannah L. Kenny
WSWilliam M. Swift
William M. Swift
KCKatarina J. Catallo
Katarina J. Catallo
ZAZoe R. Apsel
Zoe R. Apsel
JDJames J. Daniero
James J. Daniero
Biomaterial-enabled de novo formation of non-fibrotic tissue in situ would provide an important tool to physicians. One example application, glottic insufficiency, is a debilitating laryngeal disorder wherein vocal folds do not fully close, resulting in difficulty speaking and swallowing. Preferred management of glottic insufficiency includes bulking of vocal folds via injectable fillers, however, the current options have associated drawbacks including inflammation, accelerated resorption, and foreign body response. We developed a novel iteration of microporous annealed particle (MAP) scaffold designed to provide persistent augmentation. Following a 14-month study of vocal fold augmentation using a rabbit vocal paralysis model, most MAP scaffolds were replaced with tissue de novo that matched the mixture of fibrotic and non-fibrotic collagens of the contralateral vocal tissue. Further, persistent tissue augmentation in MAP-treated rabbits was observed via MRI and via superior vocal function at 14 months relative to the clinical standard.

21 January 2017 in Bioengineering
Verified
Journal Article
Open access
PDF file
MCMegan Casco
Megan Casco
TOTimothy Olsen
Timothy Olsen
AHAustin Herbst
Austin Herbst
GEGrace Evans
Grace Evans
TRTaylor Rothermel
Taylor Rothermel
Frank AlexisFrank Alexis
Frank Alexis
Nanotechnologies have been integrated into drug delivery, and non-invasive imaging applications, into nanostructured scaffolds for the manipulation of cells. The objective of this work was to determine how the physico-chemical properties of magnetic nanoparticles (MNPs) and their spatial distribution into cellular spheroids stimulated cells to produce an extracellular matrix (ECM). The MNP concentration (0.03 mg/mL, 0.1 mg/mL and 0.3 mg/mL), type (magnetoferritin), shape (nanorod—85 nm × 425 nm) and incorporation method were studied to determine each of their effects on the specific stimulation of four ECM proteins (collagen I, collagen IV, elastin and fibronectin) in primary rat aortic smooth muscle cell. Results demonstrated that as MNP concentration increased there was up to a 6.32-fold increase in collagen production over no MNP samples. Semi-quantitative Immunohistochemistry (IHC) results demonstrated that MNP type had the greatest influence on elastin production with a 56.28% positive area stain compared to controls and MNP shape favored elastin stimulation with a 50.19% positive area stain. Finally, there are no adverse effects of MNPs on cellular contractile ability. This study provides insight on the stimulation of ECM production in cells and tissues, which is important because it plays a critical role in regulating cellular functions.

1 June 2022 in Acta Biomaterialia
Verified
Journal Article
Open access
LPLauren Pruett
Lauren Pruett
ATAlex L. Taing
Alex L. Taing
NSNeharika S. Singh
Neharika S. Singh
SPShayn M. Peirce
Shayn M. Peirce
DGDonald R. Griffin
Donald R. Griffin
Biomaterials capable of generating growth factor gradients have shown success in guiding tissue regeneration, as growth factor gradients are a physiologic driver of cell migration. Of particular importance, a focus on promoting endothelial cell migration is vital to angiogenesis and new tissue formation. Microporous Annealed Particle (MAP) scaffolds represent a unique niche in the field of regenerative biomaterials research as an injectable biomaterial with an open porosity that allows cells to freely migrate independent of material degradation. Recently, we have used the MAP platform to heterogeneously include spatially isolated heparin-modified microgels (heparin microislands) which can sequester growth factors and guide cell migration. In in vitro sprouting angiogenesis assays, we observed a parabolic relationship between the percentage of heparin microislands and cell migration, where 10% heparin microislands had more endothelial cell migration compared to 1% and 100%. Due to the low number of heparin microisland ratios tested, we hypothesize the spacing between microgels can be further optimized. Rather than use purely empirical methods, which are both expensive and time intensive, we believe this challenge represents an opportunity to use computational modeling. Here we present the first agent-based model of a MAP scaffold to optimize the ratio of heparin microislands. Specifically, we develop a two-dimensional model in Hybrid Automata Library (HAL) of endothelial cell migration within the unique MAP scaffold geometry. Finally, we present how our model can accurately predict cell migration trends in vitro, and these studies provide insight on how computational modeling can be used to design particle-based biomaterials.

14 February 2025 in Acta Biomaterialia
Verified
Journal Article
Open access
ENEthan Nicklow
Ethan Nicklow
LPLauren Pruett
Lauren Pruett
NSNeharika Singh
Neharika Singh
JDJames J. Daniero
James J. Daniero
DGDonald R. Griffin
Donald R. Griffin
Microporous annealed particle (MAP) scaffolds are comprised of hydrogel microparticles with inter- and intra-particle cross-links that provide structure and cell-scale porosity, making them an increasingly attractive option for injectable tissue augmentation. Many current injectable biomaterials create a substantial foreign body response (FBR), while MAP scaffolds mitigate this response and have the potential to facilitate the formation of new tissue, though this de novo tissue formation is poorly understood. Here, we leverage a subcutaneous implant model to explore the maturation of MAP implants with and without heparin microislands (µislands) over one year to identify the effect of bioactive particles on scaffold maturation. Implants were measured and explanted after 1, 3, 6, and 12 months and analyzed using immunofluorescence staining and RNA-sequencing. No fibrous capsule or significant FBR was observed, and though a significant amount of MAP remains at 12 months, we still see a volume decrease over time. Heparin µislands facilitate increased cell infiltration and recruit a wider variety of cells at 1 month than blank MAP scaffolds, although this effect diminishes after 3 months. Transcriptomics reveal a potential activation of the complement-mediated immune response at 12 months in both groups, possibly associated with pore collapse in the implants. A single 12-month sample avoided this outcome, yielding complete cell infiltration, vascularization, and substantial matrix deposition throughout. Future work will characterize the effect of implantation site and facilitate increased matrix deposition to support the scaffold and prevent pore collapse. STATEMENT OF SIGNIFICANCE: Injectable biomaterials are increasingly used clinically for soft tissue augmentation and regeneration but still face significant issues from the foreign body reaction. While some materials intentionally promote this response to stimulate collagen deposition, porous materials like MAP scaffolds can mitigate the immune response and allow for true tissue integration. However, this integration is poorly understood, particularly on long timescales, as traditional materials are dominated by inflammatory signals. In this work, we leverage a minimally inflammatory subcutaneous implant to investigate the maturation of MAP scaffolds with and without bioactive heparin-containing particles. The results presented here contribute a better understanding of the long-term material-tissue dynamics of MAP scaffolds that can inform future material design for tissue augmentation.